Drug or treatment

Faricimab clinical trials

• 13Clinical trials
• 11Countries

Newest trials

All recruiting trials (13)

• Faricimab for CNV in Presumed Ocular Histoplasmosis Syndrome

  This study tests whether Faricimab can safely and effectively treat choroidal neovascularization linked to presumed ocular histoplasmosis in adults over a 52-week period.

  Recruiting at 2 sites Phase 4 Cincinnati Eye Institute, Southwest Ohio · Cincinnati, Ohio and 1 other locations · NCT07695298

• Early imaging changes with faricimab versus biosimilar ranibizumab for diabetic retinal disease

  This trial will see if faricimab or a biosimilar ranibizumab causes different early OCT and OCTA imaging changes in adults with diabetic retinopathy or diabetic macular edema who need anti-VEGF injections.

  Recruiting Osijek University Hospital · Osijek · NCT07520045

• Personalized treat-and-extend faricimab regimen for treatment-naive polypoidal choroidal vasculopathy

  This tests whether a personalized treat-and-extend dosing schedule of faricimab (Vabysmo) helps people with newly diagnosed polypoidal choroidal vasculopathy keep or improve their vision.

  Recruiting Phase 3 Yeungnam University College of Medicine · Daegu, Namgu · NCT07461441

• RO7823653 injections, alone or with faricimab, for diabetic macular edema

  This research tests injections of RO7823653, given alone or with faricimab, in people with diabetic macular edema to see if the medication is safe and how the eye handles it.

  Recruiting at 12 sites Phase 1 Genentech, Inc. · Peoria, Arizona and 11 other locations · NCT07425522

• Faricimab for subretinal hyper-reflective material in AMD

  This study tests whether Faricimab (Vabysmo) can help reduce subretinal hyper-reflective material in adults with age-related macular degeneration.

  Recruiting at 10 sites Phase 4 Biobizkaia Health Research Institute · Córdoba, Andalusia and 9 other locations · NCT07403825

• See If Faricimab Helps Neovascular Age-related Macular Degeneration

  This study tests whether Faricimab injections every month for 4 months can help adults aged 50 and older with active neovascular AMD in at least one eye.

  Recruiting at 3 sites Phase 4 Asan Medical Center · Seongnam and 4 other locations · NCT07367282

• Effects of Faricimab on kidney function in diabetic patients

  This study is testing if a new eye injection called Faricimab can help improve kidney function in people with diabetes compared to a standard treatment.

  Recruiting University Hospital, Alexandroupolis · Alexandroupoli, Evros and 1 other locations · NCT06929507

• Comparing 8-week and 12-week follow-up intervals for treating wet AMD with faricimab

  This study is testing whether patients with wet age-related macular degeneration can benefit more from follow-up treatments every 8 weeks or every 12 weeks after their initial injections of faricimab.

  Recruiting Phase 4 Faculty Hospital Kralovske Vinohrady · Prague · NCT06875245

• Faricimab plus PRP versus vitrectomy with endolaser for proliferative diabetic retinopathy

  This trial will test whether faricimab plus panretinal photocoagulation (PRP) or vitrectomy with endolaser gives better long-term vision and fewer follow-up treatments for adults with proliferative diabetic retinopathy.

  Recruiting at 34 sites Phase 3 Jaeb Center for Health Research · Huntington Beach, California and 33 other locations · NCT06790784

• Quarterly faricimab maintenance for neovascular age-related macular degeneration

  This test will see if faricimab injections every 12–16 weeks can keep neovascular age-related macular degeneration stable after 2–4 initial loading doses.

  Recruiting Phase 4 Hospital Authority, Hong Kong · Hong Kong · NCT06742307

• Faricimab for Caucasian patients with polypoidal choroidal vasculopathy (PCV)

  This trial will test whether intravitreal faricimab injections can improve vision and lengthen time between treatments for Caucasian adults aged 50 and older with symptomatic macular PCV.

  Recruiting at 16 sites Phase 4 Association for Innovation and Biomedical Research on Light and Image · Milan and 30 other locations · NCT06709339

• Switching patients with AMD from ranibizumab or aflibercept to faricimab

  This study is testing if switching people with age-related macular degeneration from their current eye injections to a new treatment called faricimab can improve their vision and reduce the number of injections they need.

  Recruiting Nantes University Hospital · Nantes, Nantes · NCT06271330

• Comparing injections and implants for preventing vision loss from radiation retinopathy

  This study is testing whether injections or implants can help prevent vision loss in people who have had treatment for choroidal melanoma.

  Recruiting at 29 sites Phase 3 Jaeb Center for Health Research · Palo Alto, California and 28 other locations · NCT05844982

Quick answers

How many clinical trials of Faricimab are recruiting right now?

13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 11 countries. The most sites are in United States (4 trials), South Korea (2 trials), Spain (2 trials), Hong Kong (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 6, Phase 3: 3, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →